Clinical Trial: A 26-Wk Study to Assess Safety & Efficacy of Tenapanor for T/t of Chronic Idiopathic Constipation in Adults

U.S., Feb. 3 -- ClinicalTrials.gov registry received information related to the study (NCT07382167) titled 'A 26-Wk Study to Assess Safety & Efficacy of Tenapanor for T/t of Chronic Idiopathic Constipation in Adults' on Jan. 26.

Brief Summary: This is a 26-week, multi-center, randomized, double-blind, placebo-controlled study with a 4-week treatment-free Safety Follow-up period to assess the safety and efficacy of tenapanor (5 mg, 25mg, and 50 mg) in adult patients with Chronic Idiopathic Constipation (CIC) when administered twice daily for 26 consecutive weeks.

Study Start Date: Jan. 13

Study Type: INTERVENTIONAL

Condition: Chronic Idiopathic Constipation (CIC)

Intervention: DRUG: Tenapanor 5 mg BID

Patients will receive tenapanor ...